TONIX Pharmaceuticals, Inc. Elects Harvey Moldofsky, M.D., to Its Scientific Advisory Board

NEW YORK--(BUSINESS WIRE)--TONIX Pharmaceuticals, a specialty pharmaceutical company developing prescription medications for challenging disorders of the central nervous system, including fibromyalgia syndrome and post-traumatic stress disorder, announced that Professor Harvey Moldofsky, M.D., has joined the Company’s Scientific Advisory Board. Dr. Moldofsky has devoted his career to the study of sleep physiology and biologic rhythm and is renowned for his contributions to understanding the role of non-restorative sleep in fibromyalgia syndrome.

Back to news